SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016169-08-000070
Filing Date
2008-11-13
Accepted
2008-11-13 13:10:46
Documents
8
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 q3.htm 10-Q 883451
2 robertapple.htm EX-10 39095
3 petersadowski.htm EX-10 45629
4 dariocarrara.htm EX-10 33156
5 SECTION 302 CEO CERT ex311.htm EX-31 21544
6 CFO CERT EX 31.2 ex312.htm EX-31 21591
7 CEO EX 32.1 ex321.htm EX-32 9189
8 CFO EX 32.2 ex322.htm EX-32 9068
  Complete submission text file 0001016169-08-000070.txt   1064447
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 081184037
SIC: 3841 Surgical & Medical Instruments & Apparatus